European Alzheimer's Disease (AD) Therapeutics Markets

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This Research Service provides a detailed analysis of the European Alzheimer's Disease (AD)therapeutics market. It includes the challenges faced by market participants, drivers and restraints in the industry, R & D trends, competitive structure, the revenue forecasts across different segments and countries, pipeline analysis of major players, and strategic recommendations to market participants, and decision support databases.

Table of Contents

European Alzheimer's Disease (AD) Therapeutics Markets, Executive SummarySummary of the European Alzheimer's Disease (AD) Therapeutics MarketKey Features of the European Alzheimer's Disease (AD) Therapeutics MarketEuropean Alzheimer's Disease (AD) Therapeutics Markets, Glossary of TermsList of TermsAbbreviations for the European AD Therapeutics MarketEuropean Alzheimer's Disease (AD) Therapeutics Markets, Market Engineering Research MethodologyDescription of Research MethodologyResearch Methodology for the European AD Therapeutics MarketEuropean Alzheimer's Disease (AD) Therapeutics Markets, Industry ChallengesChallenges and IssuesMain Challenges Facing the European AD Therapeutics MarketMarket Engineering Research of the European Alzheimer's Disease Therapeutics MarketForecasts of the Overall MarketIntroductionDisease BurdenPrevalence and IncidencePharmacological Treatment OptionsMarket Engineering MeasurementsMarket DriversMarket RestraintsRevenue ForecastsGeographic TrendsSegment-wise TrendsCompetitive StructureMarket Share AnalysisEuropean Alzheimer's Disease (AD) Therapeutics Markets, Segment-wise TrendsAcetyl Cholinesterase (AChEI) InhibitorsMarket OverviewMarket Engineering MeasurementsN-methyl D-aspartate (NMDA) Receptor AntagonistsMarket OverviewMarket Engineering MeasurementsEuropean Alzheimer's Disease (AD) Therapeutics Markets, Opportunities by Geographic RegionOpportunities in FranceMarket OverviewMarket Engineering MeasurementsPricing and ReimbursementOpportunities in GermanyMarket OverviewMarket Engineering MeasurementsPricing and ReimbursementOpportunities in SpainMarket OverviewMarket Engineering MeasurementsPricing and ReimbursementOpportunities in the United KingdomMarket OverviewMarket Engineering MeasurementsPricing and ReimbursementOpportunities in ItalyMarket OverviewMarket Engineering MeasurementsPricing and ReimbursementEuropean Alzheimer's Disease (AD) Therapeutics Markets, Brand AnalysisAnalysis of leading Brands in the World AD Therapeutics MarketAriceptReminylExelonEbixaEuropean Alzheimer's Disease (AD) Therapeutics Markets, Global Research and Development Activities Promising Research in AD TherapeuticsResearch and Development Area of FocusAcetyl Cholinesterase InhibitorsEstrogen Replacement Therapy/Hormone Replacement TherapyNerve Growth FactorsOther ApproachesEuropean Alzheimer's Disease (AD) Therapeutics Markets, Pipeline InsightAD Therapeutics in Various Phases of DevelopmentAnalysis by Phase of DevelopmentAD Therapeutics by CompanyAstrazenecaElan Corporation PlcGlaxosmithklineMerck & Co Inc.Myriad Genetics Inc.Neuropharma S.A.Novartis AGSanofi-AventisWyethEuropean Alzheimer's Disease (AD) Therapeutics Markets, Strategic RecommendationsStrategies for the European AD Therapeutics MarketRecommendations to ParticipantsEuropean Alzheimer's Disease (AD) Therapeutics Markets, Decision Support DatabasesDSD TablesPrevalence of DementiaPrevalence of Alzheimer's DiseaseMortality of Alzheimer's DiseaseMale Population above 65 YearsFemale Population above 65 YearsNumber of Beds in Psychiatric HospitalsNumber of Physicians




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.